chr3-15074275-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022340.4(RBSN):āc.1862A>Cā(p.Glu621Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_022340.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBSN | NM_022340.4 | c.1862A>C | p.Glu621Ala | missense_variant | 14/14 | ENST00000253699.7 | NP_071735.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBSN | ENST00000253699.7 | c.1862A>C | p.Glu621Ala | missense_variant | 14/14 | 1 | NM_022340.4 | ENSP00000253699.3 | ||
RBSN | ENST00000476527.6 | c.1862A>C | p.Glu621Ala | missense_variant | 13/13 | 2 | ENSP00000422551.1 | |||
ENSG00000289750 | ENST00000698784.1 | n.1277A>C | non_coding_transcript_exon_variant | 8/9 | ||||||
ENSG00000289750 | ENST00000698785.1 | n.2473A>C | non_coding_transcript_exon_variant | 14/17 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152126Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461242Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 726902
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152126Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2024 | The c.1862A>C (p.E621A) alteration is located in exon 14 (coding exon 11) of the RBSN gene. This alteration results from a A to C substitution at nucleotide position 1862, causing the glutamic acid (E) at amino acid position 621 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at